Bragar Eagel & Squire Files Class Action Against Alexandria (NYSE:ARE) for Investor Losses
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Globenewswire
- Lawsuit Background: Bragar Eagel & Squire has filed a class action lawsuit in the Central District of California against Alexandria Real Estate Equities, Inc. for investors who purchased securities between January 27, 2025, and October 27, 2025, alleging false statements that led to investor losses.
- False Statement Allegations: The complaint alleges that Alexandria made overly optimistic statements while concealing significant adverse facts about its Long Island City property, misleading investors regarding the leasing value as a life-science destination.
- Investor Rights Protection: Investors must apply by January 26, 2026, to be appointed as lead plaintiff in the lawsuit, with Bragar Eagel & Squire offering free consultations to help affected investors understand their legal rights and potential claims.
- Law Firm Overview: Bragar Eagel & Squire is a nationally recognized law firm specializing in securities, derivative, and commercial litigation, dedicated to providing legal support to individual and institutional investors to protect their rights.
Analyst Views on ARE
Wall Street analysts forecast ARE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARE is 51.53 USD with a low forecast of 15.84 USD and a high forecast of 67.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
4 Buy
11 Hold
0 Sell
Moderate Buy
Current: 58.090
Low
15.84
Averages
51.53
High
67.00
Current: 58.090
Low
15.84
Averages
51.53
High
67.00
About ARE
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
